# Novo Nordisk opens first tablet production plant in Måløv, Denmark

Novo Nordisk officially opened its first tablet production facility in Måløv, Denmark, on June 26, 2018. The plant will produce semaglutide tablets for type 2 diabetes patients.

- Type: New facility
- Announced: 2018-06-26
- Where: Måløv, Denmark
- Starts operating: 26 Jun 2018
- Status: completed
- Products: semaglutide tablets, GLP-1 tablet-form diabetes medication

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [ing.dk](https://ing.dk/artikel/novo-nordisk-aabner-i-dag-sin-foerste-fabrik-til-tablet-produktion-i-maaloev), 2018-06-26: "I dag er en stor dag både for mennesker med type 2-diabetes og for os som virksomhed."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.